Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1968 Feb;32(2):402–409. doi: 10.1111/j.1476-5381.1968.tb00982.x

Some pharmacological actions of diethyldithiocarbamate on rabbit and rat ileum.

G G Collins, G B West
PMCID: PMC1570208  PMID: 5646314

Full text

PDF
406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CALLINGHAM B. A., CASS R. A MODIFICATION OF THE BUTANOL EXTRACTION METHOD FOR THE FLUORIMETRIC ASSAY OF CATECHOLAMINES IN BIOLOGICAL MATERIALS. J Pharm Pharmacol. 1963 Oct;15:699–700. doi: 10.1111/j.2042-7158.1963.tb12865.x. [DOI] [PubMed] [Google Scholar]
  2. CARLSSON A. Detection and assay of dopamine. Pharmacol Rev. 1959 Jun;11(2 Pt 2):300–304. [PubMed] [Google Scholar]
  3. CARLSSON A., WALDECK B. A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta Physiol Scand. 1958 Dec 15;44(3-4):293–298. doi: 10.1111/j.1748-1716.1958.tb01628.x. [DOI] [PubMed] [Google Scholar]
  4. Carlsson A., Lindqvist M., Fuxe K., Hökfelt T. Histochemical amd biochemical effects of diethyldithiocarbamate on tissue catecholamines. J Pharm Pharmacol. 1966 Jan;18(1):60–62. doi: 10.1111/j.2042-7158.1966.tb07773.x. [DOI] [PubMed] [Google Scholar]
  5. Collins G. G. Inhibition of dopamine-beta-oxidase by diethyldithiocarbamate. J Pharm Pharmacol. 1965 Aug;17(8):526–527. doi: 10.1111/j.2042-7158.1965.tb07720.x. [DOI] [PubMed] [Google Scholar]
  6. DAY M. D. Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine. Br J Pharmacol Chemother. 1962 Apr;18:421–439. doi: 10.1111/j.1476-5381.1962.tb01421.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DAY M. D., RAND M. J. Evidence for a competitive antagonism of guanethidine by dexamphetamine. Br J Pharmacol Chemother. 1963 Feb;20:17–28. doi: 10.1111/j.1476-5381.1963.tb01293.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Finkleman B. On the nature of inhibition in the intestine. J Physiol. 1930 Sep 18;70(2):145–157. doi: 10.1113/jphysiol.1930.sp002683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GOLDSTEIN M., ANAGNOSTE B., LAUBER E., MCKEREGHAM M. R. INHIBITION OF DOPAMINE-BETA-HYDROXYLASE BY DISULFIRAM. Life Sci. 1964 Jul;3:763–767. doi: 10.1016/0024-3205(64)90031-1. [DOI] [PubMed] [Google Scholar]
  10. GOLDSTEIN M., LAUBER E., MCKEREGHAN M. R. STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF 3,4-DIHYDROXYPHENYLETHYLAMINE BETA-HYDROXYLASE. J Biol Chem. 1965 May;240:2066–2072. [PubMed] [Google Scholar]
  11. GOLDSTEIN M., WEISS Z. INHIBITION OF TYROSINE HYDROXYLASE BY 3-IODO-L-TYROSINE. Life Sci. 1965 Jan;4:261–264. doi: 10.1016/0024-3205(65)90126-8. [DOI] [PubMed] [Google Scholar]
  12. Goldstein M., Anagnoste B., Nakajima K. Inhibition of endogenous catecholamine biosynthesis by 3-iodo-L-tyrosine. Biochem Pharmacol. 1965 Dec;14(12):1914–1916. doi: 10.1016/0006-2952(65)90288-1. [DOI] [PubMed] [Google Scholar]
  13. Goldstein M., Nakajima K. The effect of disulfiram on the biosynthesis of catecholamines during exposure of rats to cold. Life Sci. 1966 Jan;5(2):175–179. doi: 10.1016/0024-3205(66)90131-7. [DOI] [PubMed] [Google Scholar]
  14. HAMBERGER B., MALMFORS T., NORBERG K. A., SACHS C. UPTAKE AND ACCUMULATION OF CATECHOLAMINES IN PERIPHERAL ADRENERGIC NEURONS OF RESERPINIZED ANIMALS, STUDIED WITH A HISTOCHEMICAL METHOD. Biochem Pharmacol. 1964 Jun;13:841–844. doi: 10.1016/0006-2952(64)90026-7. [DOI] [PubMed] [Google Scholar]
  15. HILLARP N. A., MALMFORS T. RESERPINE AND COCAINE BLOCKING OF THE UPTAKE AND STORAGE MECHANISMS IN ADRENERGIC NERVES. Life Sci. 1964 Jul;3:703–708. doi: 10.1016/0024-3205(64)90021-9. [DOI] [PubMed] [Google Scholar]
  16. IVERSEN L. L. INHIBITION OF NORADRENALINE UPTAKE BY DRUGS. J Pharm Pharmacol. 1965 Jan;17:62–64. doi: 10.1111/j.2042-7158.1965.tb07572.x. [DOI] [PubMed] [Google Scholar]
  17. MCEWEN L. M. The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain. J Physiol. 1956 Mar 28;131(3):678–689. doi: 10.1113/jphysiol.1956.sp005493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MUSACCHIO J., KOPIN I. J., SNYDER S. EFFECTS OF DISULFIRAM ON TISSUE NOREPINEPHRINE CONTENT AND SUBCELLULAR DISTRIBUTION OF DOPAMINE, TYRAMINE AND THEIR BETA-HYDROXYLATED METABOLITES. Life Sci. 1964 Jul;3:769–775. doi: 10.1016/0024-3205(64)90032-3. [DOI] [PubMed] [Google Scholar]
  19. Musacchio J. M., Goldstein M., Anagnoste B., Poch G., Kopin I. J. Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo. J Pharmacol Exp Ther. 1966 Apr;152(1):56–61. [PubMed] [Google Scholar]
  20. SHORE P. A., OLIN J. S. Identification and chemical assay of norepinephrine in brain and other tissues. J Pharmacol Exp Ther. 1958 Mar;122(3):295–300. [PubMed] [Google Scholar]
  21. Thoenen H., Haefely W., Gey K. F., Hürlimann A. Diminished effects of sympathetic nerve stimulation in cats pretreated with disulfiram; liberation of dopamine as sympathetic transmitter. Life Sci. 1965 Nov;4(21):2033–2038. doi: 10.1016/0024-3205(65)90319-x. [DOI] [PubMed] [Google Scholar]
  22. UDENFRIEND S., BOGDANSKI D. F., WEISSBACH H. Fluorescence characteristics of 5-hydroxytryptamine (serotonin). Science. 1955 Nov 18;122(3177):972–973. doi: 10.1126/science.122.3177.972. [DOI] [PubMed] [Google Scholar]
  23. Udenfriend S., Zaltzman-Nirenberg P., Nagatsu T. Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol. 1965 May;14(5):837–845. doi: 10.1016/0006-2952(65)90103-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES